New Philippines Pharmacovigilance Report for January 2023 Released: 112,103 Reports of Suspected Adverse Reactions, 10,521 Serious Events including 2,796 Deaths (+10 new).

FDA reminds readers that benefits far outweigh any current known adverse reactions in the majority of vaccinated individuals. Monitoring and reporting systems fall far short to capture outcomes!

The Philippines FDA has just released the January 2023 Reports of Suspected Adverse Reactions following Covid-19 Vaccination. Reports of adverse reactions continue to trickle in even as vaccine dosing has dropped.

The first statement in the forward is still that benefits far outweigh risks for most vaccinated individuals.

In the January report, compared to December 2022, there are 444,427 new doses of vaccines delivered with a partial breakdown of 69,520 new people fully vaccinated and 201,350 additional 1st boosters. There are now 112,103 reports of suspected adverse reactions (+464 additional reports) including 39 new serious reactions, and 10 new deaths to bring total reported deaths up to 2,796. The benefits did not far outweigh the risks for these people who reported these outcomes, or who paid with death!

The January 2023 report, for the first time, included disaggregated data on the adverse reactions, to show breakdown by vaccine brand and age. Very notable are the listed adverse reactions reported from < 12 yo children to Moderna and Janssen products; these products were never approved for children (only Comirnaty and CoronaVac were approved for children < 12 years). What madness allowed children to receive unapproved products? How many other children were dosed with unauthorized products? How many people have been overdosed with more doses than authorized?

Again, they conclude the report stating, “benefits of the vaccines in the prevention of COVID-19 and severity of disease outweighs any current known reactions in the majority”.

DOH-FDA still didn’t get the memo that these products DO NOT prevent COVID-19! That vaccinated individuals are increasingly being seen as MORE LIKELY to get seriously ill and are MORE LIKELY to die from Covid-19. That is even before adverse reactions are factored in.

Long term Monitoring for Effects

DOH OIC Vergeire, last March 2022, was excerpted as stating that the Covid-19 vaccines have to be monitored for long-term effects.

These FDA Pharmacovigilance reports typically capture just some of the acute and mostly short-term outcomes. With reference to international pharmacovigilance, these systems are well known to grossly underreporting adverse events by a factor of at least 40. In the Philippines this may be far greater: many people still do not know about this reporting system, or do not have the skills or means to do the required online reporting. Even from those who do know, many are reluctant to report, even when offered assistance to do so.

Medium term impacts are hard to pickup: many people do not link their inability to get or stay pregnant, their cancer, their heart attack, their new autoimmune condition with the vaccine that they took 6 months, 12 months or even 18 months ago. These outcomes are not being captured.

Population vital statistics could provide a means of identifying concerns, however, these are also not being collected and collated in a timely or complete enough manner to allow an alarm signal to be generated. Current increases in cardiovascular disease and cancers are being shrugged off as lifestyle related.

Long-term results will take decades to become apparent. Epigenetic effects may take even longer - by definition, generations. How can these be detected if experts do not set up systems to identify them?

All Cause Mortality to Assess Population Outcomes

All-cause mortality is the most reliable way to detect population outcomes, as it reflects the sum of all inputs on population health. Improving or worsening overall population health outcomes are reflected.

The PSA does collect all-cause mortality population data. However, the compilation and release of this data is delayed by months to years, from the actual date of death.

2021 population-wide vital statistics data was only released on 24th February 2023 (still incomplete and only compiled as of 31 March 2022). 2022 data has been released as of 31 October 2022, but is clearly still very incomplete containing minimal 3rd quarter and no 4th quarter data. While PSA should update 2022 data in the coming months, it will not be released in as complete as available form and with data breakdowns until early 2024.

The release of population data is not timely enough or complete enough to be useful to assess population outcomes. Who is monitoring the outcomes on population health? Worldwide deaths are soaring and births are plummeting. Local anecdotal accounts of sudden and unexpected illness, and deaths abound.

Are the officials fiddling while the nation burns? Nothing to see folks!